The GIFT Nifty futures, which is an early indicator of the Nifty50 index, was trading 0.18% lower by 44 points at 24,380, indicating that the domestic benchmark indices are likely to make a negative start on Wednesday.

On Tuesday, 29 April, Domestic benchmark indices S&P BSE Sensex gained by 70.01 points or 0.09% and settled at 80,288, while the Nifty50 traded 0.03% higher by 7.45 points, settling at 24,335.

Here are some stocks that are likely to remain in focus on 30 April.

Quarterly Results Today: Adani Power, Indus Towers, Indian Oil Corporation, CRISIL, Equitas Small Finance Bank, Exide Industries, Ajanta Pharma, Bandhan Bank, Coromandel International, Federal Bank, Godrej Agrovet, Greaves Cotton, JSW Infrastructure, KSB, Paras Defence and Space Technologies, Greaves Cotton, Orient Green Power Company, Jindal Steel & Power, Phoenix Mills, Skipper, Sona BLW Precision Forgings, Ujjivan Small Finance Bank, Varun Beverages, and Vedanta are some of the prominent companies set to announce their quarterly earnings for January-March. 

Alembic Pharma: Alembic Pharmaceuticals has received clearance from the US FDA for one of its major production sites. The company was issued an Establishment Inspection Report (EIR) for its oncology formulation plant (F-2) located in Panelav. The inspection, conducted in October 2024, covered the manufacturing of both injectable and oral solid dosage forms.

Prestige Estates: Prestige Estates Projects is set to debut in the National Capital Region with a new residential venture. The company has secured RERA approval for its upcoming project, The Prestige City – Indirapuram, which boasts a significant gross development value exceeding Rs 9,000 crore.

Strides Pharma: Strides Pharma Inc., the US-based subsidiary of the company, has acquired four approved Abbreviated New Drug Applications (ANDAs) from Nostrum Laboratories Inc., USA. The acquired portfolio includes liquid and immediate-release solid oral medications across key therapeutic areas such as urinary tract infections (UTIs), pain relief, allergy treatment, attention deficit disorder (ADD/ADHD), and narcolepsy.

Infosys: The digital services and consulting firm has unveiled Infosys Topaz for SAP S/4HANA Cloud, an AI-first suite designed to support enterprises in leveraging AI and generative AI during their SAP S/4HANA Cloud transformation efforts.

State Bank of India: SBI is preparing for a significant capital-raising initiative. The bank’s board is scheduled to meet this Saturday to consider various fundraising avenues for the 2025–26 fiscal year. Options under review include a follow-on public offer (FPO), a rights issue, or a qualified institutional placement (QIP). As per a regulatory filing, this strategic move reflects the bank’s focus on strengthening its capital base to support future expansion.

Bharat Petroleum: In its quarterly earnings for January-March, the company reported an 8.3% year-on-year (YoY) decline in consolidated net profit to Rs 4,392 crore for the quarter under review compared to Rs 4,789.5 crore reported in the same quarter last year. 

Tired of guessing stocks to trade in daily?
Unicorn Signals empowers you with powerful tools like daily stock scans for Intraday, Swing & Investing, Market Predictions and much more. Download the Unicorn Signals app today and take control of your investments!